186
186
Jun 19, 2017
06/17
by
CNBC
tv
eye 186
favorite 0
quote 0
clovis having data out on its ovarian cancer drug, saying they plan to apply for expanded approval ofwithin four months and showing you tesaro, it did regain losses earlier in the day, this morning it was down as much as 10%, that's because these two companies are really competing in the same space. analysts coming out today saying these data from clovis really imply these drugs look nr similar than different this is a potential m&a story, both names have been talked about as potential ramping up te about clovis along the similar vain, we're looking at exelocis. expanded approval of one of their cancer drugs the stock closing the day up 12%. also mention biogen getting an upgrade from ubs today only to neutral. had a sell rating on the stock which you don't see too often. biogen up. contributing to a move upward for the day in the biotech ebf closing up 2.4%. before we talk about health care today, i have to mention valiant. that having positive news today. as shareholder john paulson joined the board closing up 6.4%. they've been on a roll of positive news lately we'll be waufing clo
clovis having data out on its ovarian cancer drug, saying they plan to apply for expanded approval ofwithin four months and showing you tesaro, it did regain losses earlier in the day, this morning it was down as much as 10%, that's because these two companies are really competing in the same space. analysts coming out today saying these data from clovis really imply these drugs look nr similar than different this is a potential m&a story, both names have been talked about as potential...
55
55
Jun 19, 2017
06/17
by
BLOOMBERG
tv
eye 55
favorite 0
quote 0
some big movers within the drug industry, clovis oncology, those shares are soaring. the company's drug to treat ovarian cancer delays the progression of the cancer and the shares are spiking by 43% this morning. o which makes a competing drug is falling in early trading. about 90ank you, we're minutes to the close of trading in europe. seeing european equities rebounding from a two-week decline. the stocks six hundred was down of 1%.re up about 8/10 this is by region. you got austria, denmark, finland and france was hire earlier. it is green across the wheel for european stocks. when it comes to the euro, we see some week pricing because of dollar strength coming in. said theudley tightening cycle would imperil the economy and we are seeing dollar strength with the 10 year treasury yields moving higher. higher in theg u.k. in germany as well and that's having a weakening effect on the euro. this is leveraged funds and they have now moved to a net long position. since the first time 2014. if we are looking at sterling, we have been seeing sterling fairly steady today
some big movers within the drug industry, clovis oncology, those shares are soaring. the company's drug to treat ovarian cancer delays the progression of the cancer and the shares are spiking by 43% this morning. o which makes a competing drug is falling in early trading. about 90ank you, we're minutes to the close of trading in europe. seeing european equities rebounding from a two-week decline. the stocks six hundred was down of 1%.re up about 8/10 this is by region. you got austria, denmark,...
132
132
Jun 20, 2017
06/17
by
KQED
tv
eye 132
favorite 0
quote 0
. >>> clovis said its study has met its goals in the late-stage study. it had a meaningful impact on delaying disease reoccurrence in patients who had an advanced form of ovarian cancer. clovis said it plans to it apply for regulatory approval within the next four months. shares soared as you can imagine. they were up by 46-plus percent to $87 .88. >>> china's stock markets are some of the world's biggest but it hasn't always been easy for investors to gain access. that could change tomorrow if a major index provider decides to include shares of some chinese companies. bob pisani describes why global investors are paying close attention. >> reporter: this is a big deal because indexes like msci rule the world since they determine what goes into all these etfs that we're buying. right now, only hong kong-listed stocks are included in the indexes. there are no mainland china stocks in it right now. mainland china's stock market is worth $6 trillion. that's the same essentially as the hong kong stock market. $6 trillion is almost one-tenth of the total stoc
. >>> clovis said its study has met its goals in the late-stage study. it had a meaningful impact on delaying disease reoccurrence in patients who had an advanced form of ovarian cancer. clovis said it plans to it apply for regulatory approval within the next four months. shares soared as you can imagine. they were up by 46-plus percent to $87 .88. >>> china's stock markets are some of the world's biggest but it hasn't always been easy for investors to gain access. that could...
114
114
Jun 19, 2017
06/17
by
CNBC
tv
eye 114
favorite 0
quote 0
now we are seeing clovis is getting this as well >> now clovis looks like a prime candidate and this around tesaro you can see the differential there. >> different things going on and jp morgan is saying these data should narrow differential a little bit there will be a lot of speculations continuing about that of course, these are not the only companies in the space. so it is a really tight race but always good to see good news of drugstores fighting for positive causes >> we have been talking so much about amazon tell us the story about amazon expanding its regions to hospitals, is it alexa or the e echo >> this is the story on our cnbc.com today of course, we had a story s suggesting amazon is getting into pharmacy. it is a great story and i u suggest people reading it on the website. we saw implications for pharmacy stocks on the whole foods acquisition from amazon. you see walgreens and cvs is getting hit very hard here >> it could be helpful in the hospital settings but it could be weeks away. >> separate unrelated story. do you think amazon will ever be of real estate i wonder
now we are seeing clovis is getting this as well >> now clovis looks like a prime candidate and this around tesaro you can see the differential there. >> different things going on and jp morgan is saying these data should narrow differential a little bit there will be a lot of speculations continuing about that of course, these are not the only companies in the space. so it is a really tight race but always good to see good news of drugstores fighting for positive causes >> we...
152
152
Jun 19, 2017
06/17
by
CNBC
tv
eye 152
favorite 0
quote 0
clovis should be a prime takeover candidate now, which may be why you're seeing the shares up so muchlked about target b we are also watching seattle genetics that stock is getting hit as it discontinue as clinical trial for acute myeloid luka and valeant saying paulson has been added to the board and he said he's fully supportive of the strategy and brilliant team at vibrant >> a lot of movers no your space today, meg thank you very much. >> and coming up, we'll tack about the future of the retale indust -- retail industry. -- retail industry. and the dow is u p 106.50 (bell rings) parts a and b and want more coverage, guess what? you could apply for a medicare supplement insurance plan whenever you want. no enrollment window. no waiting to apply. that means now may be a great time to shop for an aarp medicare supplement insurance plan, insured by unitedhealthcare insurance company. medicare doesn't cover everything. and like all standardized medicare supplement insurance plans, these help cover some of what medicare doesn't pay. so don't wait. call now to request your free decision
clovis should be a prime takeover candidate now, which may be why you're seeing the shares up so muchlked about target b we are also watching seattle genetics that stock is getting hit as it discontinue as clinical trial for acute myeloid luka and valeant saying paulson has been added to the board and he said he's fully supportive of the strategy and brilliant team at vibrant >> a lot of movers no your space today, meg thank you very much. >> and coming up, we'll tack about the...
160
160
Jun 28, 2017
06/17
by
FOXNEWSW
tv
eye 160
favorite 0
quote 0
and and amy clovis are, tammy duckworth, sheryl sandberg, anything missing from the list?ale option took notice. i don't see nikki haley, she could have been an option. no gop woman is more pro-democrats and pro-women. are you the official magazine of the dnc? >> the assumption is donald trump might -- >> 2017. >> hillary clinton is not on that list. rick perry had a funny day. >> looks like rick perry was having a great time at a white house press briefing. he didn't seem to want to leave. he was up there for over half an hour and a lot of people on social media thought this was a lot of fun and sweeting about it, rick perry holding onto the side of the podium like he doesn't want to leave but sarah huckabee sanders trying to get in his way. he was having a lot of fun, the only person in the room that was. she deserved 30 minutes. thanks. >> time to check what is coming up on "fox and friends". >> in chester county, south carolina, i was born right near there. >> this is an amazing place, rocking and rolling already, barely 5:45 or 5:50, a country omelette lining up and t
and and amy clovis are, tammy duckworth, sheryl sandberg, anything missing from the list?ale option took notice. i don't see nikki haley, she could have been an option. no gop woman is more pro-democrats and pro-women. are you the official magazine of the dnc? >> the assumption is donald trump might -- >> 2017. >> hillary clinton is not on that list. rick perry had a funny day. >> looks like rick perry was having a great time at a white house press briefing. he didn't...
206
206
Jun 10, 2017
06/17
by
WPVI
tv
eye 206
favorite 0
quote 0
>> sal: the champion from clovis unified feudman elementary in fresno, california, ananya vinay! ] i'll sit right here. >> sal: what is ananya's first word? >> guillermo: salute. >> definition, please? >> guillermo: it is a word that has letters say-lute. >> lang wing uage of origin? >> guillermo: mine -- all the words. >> sal: no, the word. the word. >> guillermo: say-lute. >> s-a-l-u-t-e. >> sal: he's trying to say sleuth. the word is sleuth. all right, from kenny guinn jr. high school in las vegas, nevada, two-time champion, jimmy kimmel! [ cheers and applause ] >> guillermo: good luck. >> jimmy: thank you. >> guillermo: jamuke. >> jimmy: can you repeat the word? >> guillermo: ja-mul-kay. >> jimmy: i'm going to guess this is a hebrew word. y-a-r-m-u-l-k-e. [ cheers and applause ] >> sal: wow, that's right, that's right, on the board! yarmulke. >> jimmy: can i tell you something, ananya? i'm not even jewish. >> sal: let's try to even things up. what's ananya's next word. >> guillermo: come on, ananya, concentrate. co-lease-y. >> what's the word again? >> guillermo: co-lease-y.
>> sal: the champion from clovis unified feudman elementary in fresno, california, ananya vinay! ] i'll sit right here. >> sal: what is ananya's first word? >> guillermo: salute. >> definition, please? >> guillermo: it is a word that has letters say-lute. >> lang wing uage of origin? >> guillermo: mine -- all the words. >> sal: no, the word. the word. >> guillermo: say-lute. >> s-a-l-u-t-e. >> sal: he's trying to say sleuth. the...
144
144
Jun 20, 2017
06/17
by
CNBC
tv
eye 144
favorite 0
quote 0
a cancer drug to clovis also helping the story. >> i think healthcare is bouncing back from last yearse they were one of the worst groups, but one of the challenges is cpis did s didisn is being driven by healthcare. >> you spoke earlier about deregulation and the way that could help the bank sector in particular many people skeptical of when we see that delivered on. what is your estimate for when the trump administration can deliver on some promises volatility in currencies has picked up but that has not played into the equity market yet. >> i think legislation agenda has been pushed out. tax reform, healthcare reform are tougher things to count on but with regard to the banks, things like the epa, these are more dependent on agency action. i think it's easier for banks to see deregulation >> even on that point, there's loads of posts that need to be filled before the deregulation can happen no closer to doing that either >> yeah. that's another good point. any time you rely on agenc staffing to implement something, that's where trump's administration can have some effect because if
a cancer drug to clovis also helping the story. >> i think healthcare is bouncing back from last yearse they were one of the worst groups, but one of the challenges is cpis did s didisn is being driven by healthcare. >> you spoke earlier about deregulation and the way that could help the bank sector in particular many people skeptical of when we see that delivered on. what is your estimate for when the trump administration can deliver on some promises volatility in currencies has...
160
160
Jun 8, 2017
06/17
by
WUSA
tv
eye 160
favorite 0
quote 0
comey's testimony could be clovis. and today, we got the pre-splosion.ause at comey's insistence, the senate published his pre-written opening remarks. this afternoon and... i have them right here. ( cheers and applause ) you guys know that. you know this? he published this. this is true. they just published it, like, a couple of hours ago, and this thing is full of juicy details because, as promised, comey took notes after every interaction with donald trump, starting with their first meeting back in january, when comey writes, "i felt compelled to document my first conversation with the president-elect in a memo. to ensure accuracy, i began to type it on a laptop in an f.b.i. vehicle outside trump tower the moment i walked out of the meeting." ( applause ) "dear diary, i needed to write down my thoughts immediately because that guy is so darn normal. ( laughter ) note to self: can you purell your brain? love, me." now, all in all-- all in all, comey says he spoke with trump nine times in four months. in contrast, he spoke with president obama only twic
comey's testimony could be clovis. and today, we got the pre-splosion.ause at comey's insistence, the senate published his pre-written opening remarks. this afternoon and... i have them right here. ( cheers and applause ) you guys know that. you know this? he published this. this is true. they just published it, like, a couple of hours ago, and this thing is full of juicy details because, as promised, comey took notes after every interaction with donald trump, starting with their first meeting...
119
119
Jun 19, 2017
06/17
by
CNBC
tv
eye 119
favorite 0
quote 0
clovis plans to submit an application to the fda over the next four months to expand the level. the stock, as you can see, up 45% on that news today. >> valiant pharmaceuticals is getting a boost in news that billionaire hedge fund manager john paulson has joined the company's board. they owned a 5.7% stake in valiant. the stock up 5.6%. >>> landon building is taking a 3% stake in hudson bay parent company and they are suggesting strategic alternatives, specifically a real estate deal to boston red sox mize value. >> hudson's bay is reviewing the letter and will respond in due course the stock which trades on the toronto stock exchange has been up about 15% today and joining us in a first on cnbc interview is the man in the center of all of this. founder and cio of land and buildings, jonathan litt good to see you. thanks for joining us today. >> good to sigh, bill. thanks for having me on. >> your premise is that the real estate that these stores are sitting on is worth what, five times what the stock might reflect right now. is that the idea >> right, so the company is valued
clovis plans to submit an application to the fda over the next four months to expand the level. the stock, as you can see, up 45% on that news today. >> valiant pharmaceuticals is getting a boost in news that billionaire hedge fund manager john paulson has joined the company's board. they owned a 5.7% stake in valiant. the stock up 5.6%. >>> landon building is taking a 3% stake in hudson bay parent company and they are suggesting strategic alternatives, specifically a real estate...
89
89
Jun 22, 2017
06/17
by
CNBC
tv
eye 89
favorite 0
quote 0
look at clovis recently and you have a space that wants to break out. not just saying that today, by the way. we've been saying that the last three months >> after a big move, do you wake up tomorrow morning and buy into this as a trader i want to wait for a pull back, but we have been talking about how it wants to break out. if you're wrong, nothing wrong with taking profits. i agree with you, psychologically the $20 level, if you get some kind of breakout beyond that, yeah, i would chase that i would go with the momentum >> how about valium? tim, myself, karen, i don't know if b.k. is long, you're not -- >> did it go up? i'll say yes >> you should be there it's up 50%. i'm playing this thing for a move to 20 not a move to 15 i'm playing this because this was something that was going out of business. it was a very expensive option, but i'm playing for a move to 20 or 30. >> you think that's impacted by the health care? i feel that's just kind of an individual store >> this is dragged higher. >> dragged higher. >> dragged higher. >> in a less predatory
look at clovis recently and you have a space that wants to break out. not just saying that today, by the way. we've been saying that the last three months >> after a big move, do you wake up tomorrow morning and buy into this as a trader i want to wait for a pull back, but we have been talking about how it wants to break out. if you're wrong, nothing wrong with taking profits. i agree with you, psychologically the $20 level, if you get some kind of breakout beyond that, yeah, i would...
50
50
Jun 19, 2017
06/17
by
BLOOMBERG
tv
eye 50
favorite 0
quote 0
clovis oncology.,rug showed positive data giving it a broader label for the company. something investors are clearly cheering. the data makes the company a prime takeover candidate. equally impressive is that stock is up over 350%. this company already has the broader label for its ovarian cancer drugs keeping investors a bit wary. analysts intelligence said that one benefit to sorrow has is timing -- tesaro has is timing. billionaire john paulson has joined the board to help with the takeover three months after a fellow hedge fund or exited his position at a loss. stock down about 90%. quite a takeover ahead. david: when news of amazon buying whole foods crossed the wires it rocked the world of grocery sales and online retailing. coming war the between amazon and walmart and raised real questions about how walmart is trying to move online lori in.com's mark charge of efforts. accomplishedte setting up the domain names diapers.com and soak.com. he had a ton of money. that compares to amazon's growth m
clovis oncology.,rug showed positive data giving it a broader label for the company. something investors are clearly cheering. the data makes the company a prime takeover candidate. equally impressive is that stock is up over 350%. this company already has the broader label for its ovarian cancer drugs keeping investors a bit wary. analysts intelligence said that one benefit to sorrow has is timing -- tesaro has is timing. billionaire john paulson has joined the board to help with the takeover...
354
354
Jun 19, 2017
06/17
by
CNBC
tv
eye 354
favorite 0
quote 1
give the meal kit delivery company a valuation as high as $3.2 billion a company of pharma stocks, clovisa test of the company's ovarian drug, ovarian cancer drug showed similar efficacy to a competing drug these drug belong to a closely watched class of new medicines called parp inhibitors and the results could help and differentiate it from rivals we mentioned tesaro. those shares are down on the news >>> some months after the election americans weigh in on the economy and the outlook for their wages and their hopes. senior economics reporter steve liesman joins us with the exclusive cnbc all-america survey >> economic optimism remains strong as the post election bump continues and it's even strengthening. the percentage of americans who are optimistic about the current situation, and optimistic about the future, at a record 30%. spurred by surging public optimism, and democratic pessimism that sparked below republican levels during the obama years. you can look at this chart kind of optimism flattened out -- oh, move on to the next one here anyway, behind this optimism, the percentage
give the meal kit delivery company a valuation as high as $3.2 billion a company of pharma stocks, clovisa test of the company's ovarian drug, ovarian cancer drug showed similar efficacy to a competing drug these drug belong to a closely watched class of new medicines called parp inhibitors and the results could help and differentiate it from rivals we mentioned tesaro. those shares are down on the news >>> some months after the election americans weigh in on the economy and the...